PROFUND ADVISORS LLC – Regeneron Pharmaceuticals, Inc. Transaction History
PROFUND ADVISORS LLC portfolio value:
$11.90M
portfolio value
PROFUND ADVISORS LLC quarter portfolio value change:
+16.53%
quarter
Regeneron Pharmaceuticals, Inc. 13F transactions
Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
---|---|---|---|---|---|---|---|
Q3 2022 | share | Decrease | -5.58% | -1.02K shares | 1.08M | $688.87 | 17.28K |
Q2 2022 | share | Decrease | -10.11% | -2.05K shares | -3.40M | $591.13 | 18.30K |
Q1 2022 | share | Decrease | -16.86% | -4.13K shares | -1.24M | $698.42 | 20.36K |
Q4 2021 | share | Decrease | -10.07% | -2.74K shares | -1.01M | $642.51 | 24.49K |
Q3 2021 | share | Increase | +0.22% | 61 shares | 1.30M | $605.18 | 27.23K |
Q2 2021 | share | Decrease | -3.32% | -932 shares | 1.88M | $558.54 | 27.17K |
Q1 2021 | share | Decrease | -2.36% | -680 shares | -608K | $473.14 | 28.10K |
Q4 2020 | share | Increase | +8.82% | 2.33K shares | -902K | $483.11 | 28.78K |
Q3 2020 | share | Decrease | -8.50% | -2.45K shares | -3.22M | $559.78 | 26.45K |
Q2 2020 | share | Increase | +34.13% | 7.35K shares | 7.50M | $623.65 | 28.91K |
Q1 2020 | share | Decrease | -24.53% | -7.00K shares | -198K | $488.29 | 21.55K |
Q4 2019 | share | Increase | +11.38% | 2.91K shares | 3.61M | $375.48 | 28.55K |
Q3 2019 | share | Decrease | -3.72% | -991 shares | -1.22M | $277.4 | 25.64K |
Q2 2019 | share | Decrease | -5.98% | -1.69K shares | -3.29M | $313 | 26.63K |
Q1 2019 | share | Increase | +2.34% | 647 shares | 1.29M | $410.62 | 28.32K |
Q4 2018 | share | Decrease | -19.24% | -6.59K shares | -3.51M | $373.5 | 27.68K |
Q3 2018 | share | Increase | +9.28% | 2.91K shares | 3.02M | $404.04 | 34.27K |
Q2 2018 | share | Decrease | -4.47% | -1.46K shares | -486K | $344.99 | 31.36K |
Q1 2018 | share | Decrease | -6.27% | -2.19K shares | -1.86M | $344.36 | 32.83K |
Q4 2017 | share | Decrease | -9.10% | -3.50K shares | -4.06M | $375.96 | 35.02K |
Q3 2017 | share | Increase | +8.81% | 3.11K shares | -165K | $447.12 | 38.53K |
Q2 2017 | share | Decrease | -5.05% | -1.88K shares | 2.94M | $491.14 | 35.41K |
Q1 2017 | share | Decrease | -5.42% | -2.13K shares | -23K | $387.51 | 37.29K |
Q4 2016 | share | Decrease | -12.03% | -5.39K shares | -3.54M | $367.09 | 39.43K |
Q3 2016 | share | Decrease | -6.36% | -3.04K shares | 1.30M | $402.02 | 44.82K |
Q2 2016 | share | Decrease | -4.88% | -2.45K shares | -1.42M | $349.23 | 47.87K |
Q1 2016 | share | Decrease | -18.01% | -11.05K shares | -15.18M | $360.44 | 50.32K |